Synthetic Biology Market to Surge Ahead at 32.6% CAGR From 2013 - 2019 Supported by Healthcare Applications
Synthetic biology is on the path to becoming a US$13.4 billion market by 2019, exhibiting a sharp CAGR of 32.6% between 2013 and 2019, estimates Transparency Market Research in its latest report. The report, titled “Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019”, puts the value of the market at US$1.8 billion in 2012.Synthetic biology is a process that utilizes biology and genetic engineering to produce artificial biological systems and devices.
The process is proving to be especially pivotal in producing affordable medicines and improved nutritional products. The report zeroes in the following key factors that have shaped the growth curve of the global synthetic biology market: Increased government participation and investments being routed into scientific research as well as active initiatives taken by private players in R&D.
Besides pharmaceutical and nutrition-related applications, synthetic biology has been used for mitigating the damaging effects of marine pollution. The process has been extensively applied for developing engineered microorganisms to limit oil spill damages. Additionally, researchers have successfully used synthetic biology to convert regular plastics into microplastics that can be re-used. With DNA sequencing prices taking a plunge, the synthetic biology market will gain momentum. However, the global synthetic biology market is still impeded by ethical issues relating to synthetic biology products.
Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=421
Synthetic Biology Market Segmentation by Product, Application, and Technology
The TMR reports offers a highly detailed study of the global synthetic biology market by classifying it on three fronts: Application, products and technologies.
By application, the synthetic biology market is classified according to sectors such as: Healthcare, chemicals, agriculture and others. Of these, the healthcare segment will demonstrate continued growth thanks to factors such synthetic DNA and genes now being commercially available, which in turn supports the development of affordable pharma products.
The segmentation of the synthetic biology market by product has been done as follows: Core products and enabling products. The core products segment is further segregated as: XNA, synthetic DNA, synthetic cells, synthetic genes, and chassis organisms. The enabling products segment, on the other hand, is further divided into products for oligonucleotide synthesis and those for DNA synthesis. According to 2012 estimates, the core products segment enjoyed a larger share of market revenues as compared to enabling products. Based on the type of technology used in synthetic biology processes, the market is segmented as: Biological components and integrated systems, genome engineering, bioinformatics, and DNA sequencing. Technology for synthetic biology genome engineering is observed to be the most widely used as of 2012, because it can efficiently modify specific areas within the DNA to attain better reproducibility.
Regional and Competitive Analysis of the Synthetic Biology Market
Findings of the TMR report indicate that Europe will lead the synthetic biology market through the forecast period as a result of active government initiatives and milestones achieved by private players. North America followed Europe in terms of market share as of 2012 through the launch of innovative technologies. Players that yield maximum influence over the synthetic biology market are: DuPont, Inc., Bayer AG, Amyris, Inc., Ginkgo Bioworks, Royal DSM, and Life Technologies Corporation.
Browse the full Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019 report at http://www.transparencymarketresearch.com/synthetic-biology-market.html
The process is proving to be especially pivotal in producing affordable medicines and improved nutritional products. The report zeroes in the following key factors that have shaped the growth curve of the global synthetic biology market: Increased government participation and investments being routed into scientific research as well as active initiatives taken by private players in R&D.
Besides pharmaceutical and nutrition-related applications, synthetic biology has been used for mitigating the damaging effects of marine pollution. The process has been extensively applied for developing engineered microorganisms to limit oil spill damages. Additionally, researchers have successfully used synthetic biology to convert regular plastics into microplastics that can be re-used. With DNA sequencing prices taking a plunge, the synthetic biology market will gain momentum. However, the global synthetic biology market is still impeded by ethical issues relating to synthetic biology products.
Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=421
Synthetic Biology Market Segmentation by Product, Application, and Technology
The TMR reports offers a highly detailed study of the global synthetic biology market by classifying it on three fronts: Application, products and technologies.
By application, the synthetic biology market is classified according to sectors such as: Healthcare, chemicals, agriculture and others. Of these, the healthcare segment will demonstrate continued growth thanks to factors such synthetic DNA and genes now being commercially available, which in turn supports the development of affordable pharma products.
The segmentation of the synthetic biology market by product has been done as follows: Core products and enabling products. The core products segment is further segregated as: XNA, synthetic DNA, synthetic cells, synthetic genes, and chassis organisms. The enabling products segment, on the other hand, is further divided into products for oligonucleotide synthesis and those for DNA synthesis. According to 2012 estimates, the core products segment enjoyed a larger share of market revenues as compared to enabling products. Based on the type of technology used in synthetic biology processes, the market is segmented as: Biological components and integrated systems, genome engineering, bioinformatics, and DNA sequencing. Technology for synthetic biology genome engineering is observed to be the most widely used as of 2012, because it can efficiently modify specific areas within the DNA to attain better reproducibility.
Regional and Competitive Analysis of the Synthetic Biology Market
Findings of the TMR report indicate that Europe will lead the synthetic biology market through the forecast period as a result of active government initiatives and milestones achieved by private players. North America followed Europe in terms of market share as of 2012 through the launch of innovative technologies. Players that yield maximum influence over the synthetic biology market are: DuPont, Inc., Bayer AG, Amyris, Inc., Ginkgo Bioworks, Royal DSM, and Life Technologies Corporation.
Browse the full Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019 report at http://www.transparencymarketresearch.com/synthetic-biology-market.html